Greenwood Capital Associates’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.3K | Sell |
22,789
-882
| -4% | -$1.98K | 0.01% | 248 |
|
|
2025
Q1 | $32.4K | Sell |
23,671
-208,087
| -90% | -$285K | ﹤0.01% | 233 |
|
|
2024
Q4 | $366K | Sell |
231,758
-26,062
| -10% | -$41.2K | 0.05% | 210 |
|
|
2024
Q3 | $320K | Sell |
257,820
-10,733
| -4% | -$13.3K | 0.04% | 212 |
|
|
2024
Q2 | $360K | Sell |
268,553
-17,409
| -6% | -$23.3K | 0.05% | 204 |
|
|
2024
Q1 | $389K | Sell |
285,962
-6,462
| -2% | -$8.79K | 0.05% | 214 |
|
|
2023
Q4 | $766K | Sell |
292,424
-9,385
| -3% | -$24.6K | 0.1% | 156 |
|
|
2023
Q3 | $966K | Sell |
301,809
-39
| -0% | -$125 | 0.14% | 135 |
|
|
2023
Q2 | $1.52M | Buy |
301,848
+16,021
| +6% | +$80.6K | 0.21% | 93 |
|
|
2023
Q1 | $823K | Sell |
285,827
-13,388
| -4% | -$38.6K | 0.12% | 147 |
|
|
2022
Q4 | $700K | Buy |
299,215
+77,909
| +35% | +$182K | 0.11% | 146 |
|
|
2022
Q3 | $994K | Buy |
221,306
+1,437
| +0.7% | +$6.45K | 0.17% | 104 |
|
|
2022
Q2 | $1.29M | Buy |
219,869
+75,576
| +52% | +$443K | 0.21% | 89 |
|
|
2022
Q1 | $942K | Buy |
144,293
+82,244
| +133% | +$537K | 0.25% | 83 |
|
|
2021
Q4 | $795K | Buy |
62,049
+7,194
| +13% | +$92.2K | 0.11% | 156 |
|
|
2021
Q3 | $760K | Buy |
+54,855
| New | +$760K | 0.12% | 142 |
|